Open access
Open access
Powered by Google Translator Translator

All Posts

How to avoid harm with feeding critically ill patients: a synthesis of viewpoints of a basic scientist, dietitian and intensivist

10 Jul, 2023 | 13:34h | UTC

How to avoid harm with feeding critically ill patients: a synthesis of viewpoints of a basic scientist, dietitian and intensivist – Critical Care

 


RCT | Atezolizumab in platinum-ineligible NSCLC elevates median survival to 10.3 months vs. 9.2 months with chemotherapy

10 Jul, 2023 | 13:33h | UTC

First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study – The Lancet (link to abstract – $ for full-text)

News Release: Immunotherapy for ‘difficult to treat’ lung cancer patients improves long-term survival – University College London

 


RCT | Perioperative nivolumab plus chemotherapy increases pathological response vs. chemotherapy alone in stage III NSCLC

10 Jul, 2023 | 13:27h | UTC

Perioperative Nivolumab and Chemotherapy in Stage III Non–Small-Cell Lung Cancer – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: Addition of Neoadjuvant Nivolumab to Platinum-Based Chemotherapy in Stage III NSCLC – The ASCO Post

 

Commentary on Twitter

 


Cohort Study | Hypertensive disorders of pregnancy linked to a 66% higher stroke risk in U.S. black women

10 Jul, 2023 | 13:31h | UTC

Hypertensive Disorders of Pregnancy and Risk of Stroke in U.S. Black Women – NEJM Medicine

Commentary: Black women with history of hypertensive disorders of pregnancy have 66% increased risk of stroke, study finds – News Medical

 


RCT | Mirikizumab outperforms placebo in inducing and maintaining remission in ulcerative colitis

10 Jul, 2023 | 13:25h | UTC

Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: Mirikizumab Bests Placebo in Treating Patients With Ulcerative Colitis – HCP Live

 

Commentary on Twitter

 


M-A | Efficacy of varenicline versus bupropion for smoking cessation

10 Jul, 2023 | 13:23h | UTC

Efficacy of varenicline versus bupropion for smoking cessation: A systematic review and meta-analysis of randomized controlled trials – Indian Journal of Psychiatry

 


Podcast | Untangling catheter associated UTIs

10 Jul, 2023 | 13:21h | UTC

#402 Don’t Get Caught with a CAUTI – The Curbsiders

 


Podcast | Updates in addiction medicine

10 Jul, 2023 | 13:17h | UTC

#401 Updates in Addiction Medicine – SGIM 2023 – The Curbsiders

 


Consensus Paper | Subcutaneous infusions of hydration and medication in adults

7 Jul, 2023 | 16:27h | UTC

International Consensus Recommendation Guidelines for Subcutaneous Infusions of Hydration and Medication in Adults: An e-Delphi Consensus Study – Journal of Infusion Nursing

 


RCT | Semont-plus maneuver yields faster recovery than Epley maneuver in posterior canal BPPV

7 Jul, 2023 | 16:26h | UTC

The Semont-Plus Maneuver or the Epley Maneuver in Posterior Canal Benign Paroxysmal Positional Vertigo: A Randomized Clinical Study – JAMA Neurology (link to abstract – $ for full-text)

See also: Visual Abstract

Videos:

Demonstration of the Semont-Plus Self-maneuver for Right Posterior Canal Canalithiasis

Semont-Plus Maneuver for Right Posterior Canal Benign Paroxysmal Positional Vertigo

Demonstration of the Epley Self-maneuver for a Right Posterior Canal Canalithiasis

Commentary: Semont-plus Meneuver Offered Faster Recovery for Benign Paroxysmal Positional Vertigo – Neurology Today

 


RCT | Weekly Tirzepatide outperforms placebo in weight management for type 2 diabetes patients

7 Jul, 2023 | 16:24h | UTC

Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial – The Lancet (link to abstract – $ for full-text)

Commentary: Tirzepatide triumphs in significant weight reduction for people with type 2 diabetes – News Medical

 


Review | Post-COVID Conditions

7 Jul, 2023 | 16:21h | UTC

Post-COVID Conditions – Mayo Clinic Proceedings

 


Review | Management of premature ventricular complexes in the outpatient setting

7 Jul, 2023 | 16:22h | UTC

Management of Premature Ventricular Complexes in the Outpatient Setting – Mayo Clinic Proceedings

 


RCT | Personalized eHealth program hastens return to normal activity post major abdominal surgery

7 Jul, 2023 | 16:20h | UTC

Personalised electronic health programme for recovery after major abdominal surgery: a multicentre, single-blind, randomised, placebo-controlled trial – The Lancet Digital Health

Invited Commentary: Individualising the recovery process through eHealth – The Lancet Digital Health

News Release: eHealth app helps patients recover from major abdominal operations 30% faster – Amsterdam University Medical Centers/News Medical

 


Consensus Paper | Adult cardiac surgery-associated acute kidney injury

7 Jul, 2023 | 16:18h | UTC

Adult Cardiac Surgery-Associated Acute Kidney Injury: Joint Consensus Report – Journal of Cardiothoracic and Vascular Anesthesia

 


Consensus Paper | Methotrexate for inflammatory skin disease in pediatric patients

7 Jul, 2023 | 16:16h | UTC

Methotrexate for inflammatory skin disease in pediatric patients: Consensus treatment guidelines – Pediatrics Dermatology

 


Consensus Paper | The place of new antibiotics for Gram-negative bacterial infections in intensive care

7 Jul, 2023 | 16:15h | UTC

The place of new antibiotics for Gram-negative bacterial infections in intensive care: report of a consensus conference – Annals of Intensive Care

 


Single-arm study | Pirtobrutinib exhibits efficacy in CLL patients after failure of covalent BTK inhibitor treatment

7 Jul, 2023 | 16:14h | UTC

Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia – New England Journal of Medicine (link to abstract – $ for full-text)

News release from the manufacturer: New England Journal of Medicine Publishes BRUIN Phase 1/2 Trial Data for Pirtobrutinib in BTK Inhibitor Pre-Treated Adult Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma – Lilly

 


Review | Cardiovascular outcomes in patients with diabetes and kidney disease

7 Jul, 2023 | 16:13h | UTC

Cardiovascular Outcomes in Patients With Diabetes and Kidney Disease: JACC Review Topic of the Week – Journal of the American College of Cardiology

 


Cohort Study | Incidence and risk factors of postoperative urinary retention after inguinal hernia repair

7 Jul, 2023 | 16:11h | UTC

Global Incidence and Risk Factors Associated With Postoperative Urinary Retention Following Elective Inguinal Hernia Repair: The Retention of Urine After Inguinal Hernia Elective Repair (RETAINER I) Study – JAMA Surgery (link to abstract – $ for full-text)

 


Review | Acute-on-chronic liver failure

7 Jul, 2023 | 16:09h | UTC

Acute-on-chronic liver failure: far to go—a review – Critical Care

Related:

EASL Clinical Practice Guidelines on acute-on-chronic liver failure – Journal of Hepatology

Guidelines for the management of adult acute and acute-on-chronic liver failure in the ICU

 


Review | Diabetes detection in women with gestational diabetes and polycystic ovarian syndrome

7 Jul, 2023 | 16:08h | UTC

Diabetes detection in women with gestational diabetes and polycystic ovarian syndrome – The BMJ

 


RCT | Brachytherapy alone sufficient for intermediate-risk prostate cancer, no FFP improvement with additional EBRT

7 Jul, 2023 | 16:06h | UTC

Effect of Brachytherapy With External Beam Radiation Therapy Versus Brachytherapy Alone for Intermediate-Risk Prostate Cancer: NRG Oncology RTOG 0232 Randomized Clinical Trial – Journal of Clinical Oncology (link to abstract – $ for full-text)

News Release: Addition of EBRT to brachytherapy did not improve outcomes for men with intermediate-risk prostate cancer, brachytherapy alone remains standard of care – NRG Oncology

 


Review | Surgical treatment options for male stress urinary incontinence

7 Jul, 2023 | 16:03h | UTC

A narrative review on surgical treatment options for male stress urinary incontinence – Translational Andrology and Urology

 


Review | Hypereosinophilic syndrome (HES) and eosinophilic granulomatosis with polyangiitis (EGPA): two sides of the same coin

7 Jul, 2023 | 16:01h | UTC

HES and EGPA: Two Sides of the Same Coin – Mayo Clinic Proceedings

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.